Safety Study of Human Recombinant Tissue Non-Specific Alkaline Phosphatase Fusion Protein Asfotase Alfa in Adults With Hypophosphatasia (HPP)
Study Identifier:
ENB-001-08
ClinicalTrials.gov Identifier:
EudraCT Identifier:
N/A
Sponsor:
Alexion Pharmaceuticals, Inc.
Study Contact Information:
N/A
Study Complete
Study Details
Medical Condition
- Unmapped
Study Drug
- Biological: Asfotase Alfa
Date
Aug 2008 - Jan 2009
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 18 - 80 Years
Requirements Information
Sex
Female & Male
Age
18 - 80 Years
Study Details
Medical Condition
- Unmapped
Study Drug
- Biological: Asfotase Alfa
Date
Aug 2008 - Jan 2009
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 18 - 80 Years years
Requirements Information
Protocol Summary
This clinical trial studies the safety, tolerability, and pharmacology of asfotase alfa when given to adults with HPP.
Trial Locations
Location
Status
Location
Barnes Jewish Hospital- Washington University School of Medicine
Saint Louis, Missouri, United States, 63110
Status
N/A
Location
Duke University Medical Center
Durham, North Carolina, United States, 27710
Status
N/A
Location
Department of Pediatrics & Child Health, Health Sciences Centre Winnipeg, University of Manitoba
Winnipeg, Manitoba, Canada, R3A 1S1
Status
N/A